Further corroborating the antagonistic role of autophagy, the clinically approved autophagy inhibitor chloroquine (Mauthe et al, 2018) potently enhances the cytotoxicity of FGFR1/PLK1 inhibitors in KRAS‐mutant lung cancer cells in vitro and in vivo. Here, FGFR1 is linked to lung carcinoma.